Medical/Pharmaceuticals
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant
BEIJING, China, Dec. 7, 2021 /PRNewswire/ -- Sino Biological, Inc. (
http://www.sinobiological.com
2021-12-07 18:18
2081
Overland Pharmaceuticals Partners with ArisGlobal to Accelerate Safety Capabilities
Premier pharmaceutical company adopts LifeSphere Multivigilance to centralize pharmacovigilance activities MIAMI, Dec. 7, 2021 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform ...
2021-12-07 17:13
1932
Samsung Biologics adds to global ISO certifications with Quality Management System
* Samsung Biologics earns ISO9001 for Quality Management System, proving its capabilities to ensure high-quality service offerings throughout a product life-cycle * The company is fully certified with the recognition across all of its CDO, CMO and all other core business units in Plant 1,2, a...
2021-12-07 13:04
1436
QUOMI Launches An Innovative, Premium, Digital, Community Network For Healthcare Professionals (HCP)
DORTMUND, Germany, Dec. 7, 2021 /PRNewswire/ -- QUOMI
2021-12-07 09:20
1987
Akeso Announces Launch of U.S. Investigator-Initiated Study of Cadonilimab (PD-1/CTLA-4 Bispecific Antibody)
HONG KONG, Dec. 6, 2021 /PRNewswire/ -- Today, Akeso, Inc. (9926.HK) announced that the company will support an investigator-initiated study (IIS) to evaluate the efficacy and safety of Akeso's novel, first-in-class anti-PD-1/CTLA-4 bispecific antibody, cadonilimab, for the treatment of neuroendo...
2021-12-07 08:20
1752
GSK Singapore Announces Additional Supply of Monoclonal Antibody Sotrovimab to the Government of Singapore
* GSK Singapore is contracted to supply the Government of Singapore with additional doses of sotrovimab, following the first purchase placed by the Ministry of Health (MOH) inJune 2021 * Sotrovimab was approved by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access...
2021-12-07 08:00
2370
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-12-07 08:00
2931
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18
BEIJING and BRIDGEWATER, N.J., Dec. 7, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the...
2021-12-07 05:54
2328
RaySearch receives large RayStation order in China for carbon ion treatment planning
RaySearch Laboratories AB (publ) announces a large order for the treatment planning system RayStation®* by Lanzhou Ion Therapy Co, LTD, a Chinese manufacturer of accelerator systems for carbon ion therapy STOCKHOLM, Dec. 7, 2021 /PRNewswire/ -- Carbon ion therapy is a highly advanced radiation t...
2021-12-07 05:51
1920
Moscow ranked first among European cities in the ranking of innovations against COVID-19
Moscow ranks third in the world, behind New York and San Francisco MOSCOW, Dec. 7, 2021 /PRNewswire/ -- Moscow is recognized as the first European city in the ranking of innovations, that are used for the formation of resilience to the coronavirus. It is ahead ofLondon and Barcelona. The Russian...
2021-12-07 02:34
2371
Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health
SYDNEY, Dec. 7, 2021 /PRNewswire/ -- The prevalence of liver health issues is emerging as a serious cost and health burden forAustralia with the spotlight on evidence-based natural ingredients that might help support liver health and possibly assist in reducing the burden of the disease[i]. A ne...
2021-12-07 01:00
2204
Broncus enter into strategic partnership with New Frontier Health Corporation /United Family Healthcare
HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Broncus Holding Corporation (2216.HK) ("Broncus"), the leader of minimally invasive diagnostic and therapeutic technology for solutions to different lung diseases inChina, today announced that it has entered into a strategic cooperation framework agre...
2021-12-06 21:44
2901
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations
Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SARS-CoV-2 variant, as well as other variants of conce...
2021-12-06 20:01
3200
Innoforce Completes Second Tranche of Series A Financing
HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Innoforce ("INF"), a biopharmaceutical manufacturing & development company, announced today the completion of a1 billion CNY ($156.6M) Series A financing, with the closing of an additional375M CNY ($58.7M) following the first tranche of 625M CNY ($96M...
2021-12-06 20:00
2151
Donisi Health Named 2021's "Future Unicorn" by E&T Magazine
MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Receives the "Future Unicorn" Innovation Award from E&T TEL AVIV, Israel, Dec. 6, 2021 /PRNewswire/ -- E&T Magazine, the official publication of the Institution of Engineering and Tec...
2021-12-06 18:59
1549
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies
HOUSTON and SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK, the world's leading cancer charity, today annou...
2021-12-06 17:30
1359
IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy
SHANGHAI, Dec. 6, 2021 /PRNewswire/ -- The 2nd R&D Day event of IMPACT Therapeutics (IMPACT) successfully took place inShanghai on December 3rd (GMT+8). With the theme of "Synthetic Lethality: A New Platform for Targeted Therapy", the event attracted nearly 300 guests offline and online. The gues...
2021-12-06 16:03
1311
Odyssey Announces Agreement to Combine with BenevolentAI
* BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines * Combination of BenevolentAI with Odyssey, a €300m Euronext Amsterdam-listed special purpo...
2021-12-06 14:00
1884
Odyssey Announces Agreement to Combine with BenevolentAI
LONDON and AMSTERDAM, Dec. 6, 2021 /PRNewswire/ -- Odyssey Acquisition S.A. ("Odyssey"), a Euronext Amsterdam-listed special-purpose acquisition company, and BenevolentAI, a leading clinical-stage AI drug discovery company, today announced that they have entered into a definitive agreement for a ...
2021-12-06 14:00
1911
Brii Biosciences Included in Hong Kong Stock Connect
DURHAM, N.C. and BEIJING, Dec. 6, 2021 /PRNewswire/ -- Brii Biosciences
2021-12-06 10:54
2672
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 319 media titles]
2024-05-08 14:37
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 310 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 297 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
15178
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10658
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
10026
